CLL Therapy Approaches in Russia

Active, not recruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (34)

Unknown

Research Site, Belgorod

Research Site, Bryansk

Research Site, Chelyabinsk

Research Site, Chita

Research Site, Irkutsk

Research Site, Kaliningrad

Research Site, Kaluga

Research Site, Kazan'

Research Site, Kirov

Research Site, Krasnoyarsk

Research Site, Kurgan

Research Site, Mahachkala

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Omsk

Research Site, Orenburg

Research Site, Perm

Research Site, Petropavlovsk-Kamchatskii

Research Site, Petrozavodsk

Research Site, Rostov-on-Don

Research Site, Saint-Petesburg

Research Site, Samara

Research Site, Saratov

Research Site, Syktyvkar

Research Site, Tver'

Research Site, Ufa

Research Site, Ulan-Ude

Research Site, Vladimir

Research Site, Vladivostok

Research Site, Volgograd

Research Site, Vologda

Research Site, Yaroslavl

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY